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There is a known effect on the vaginal microbiota by hormonal contraceptives, as well as a strong negative association between hormonal contraception and bacterial vaginosis. Is there a role for a clinical trial evaluating hormonal contraceptives as part of the treatment for women with recurrent bacterial vaginosis? 
Such a trial would be very interesting, and anything that could potentially improve treatment outcomes for women with recurrent bacterial vaginosis would be most welcome. Careful thought would be needed in the selection of a good control group, however. This is because any form of contraception may affect the vaginal microbiota in ways that are as of yet incompletely understood. For example, there is conflicting evidence about the effect of intrauterine devices (IUDs) on vaginal microflora; this may be due to the fact that researchers have grouped different types of IUDs together in their analyses

Question 2:
What do the authors think is responsible for the inconsistencies in studies on the association between sex practices (oral, anal, and vaginal) and bacterial vaginosis? Are there opportunities for improvements in sample size or study design? Response from Dr. Lewis:
The authors discuss the correlation between cigarette smoking and bacterial vaginosis in epidemiologic studies. Is there any evidence to support a resolution of dysbiosis following smoking cessation?
To my knowledge, this has only been looked at in a fascinating small pilot study by Brotman 
Question 5:
Treatment of asymptomatic bacterial vaginosis with intravaginal metronidazole was associated with a decreased incidence of chlamydia in one study, but another study utilizing home screening and treatment did not support those findings. How was home screening implemented in that study, and is there a role for improving the screening and/or treatment of bacterial vaginosis with the goal of decreasing the incidence of other sexually transmitted diseases (STDs)?
In the large randomized controlled study of home screening (Schwebke et al), 3 
It is thought that this may be in large part due to the persistence of biofilm-associated bacteria in the vagina, and current research is beginning to focus on eradication strategies for the multispecies biofilms elaborated by bacterial vaginosis-associated bacteria. If there had been a therapy available during this trial that could reliably eradicate bacterial vaginosis and its biofilms, I suspect we may have seen a decrease in associated STD rates among those who were treated. Additionally, there does seem to be increased risk of incident STD even with intermediate flora, and future studies may show that treatment is indicated for those with Nugent scores of 4-6.
Response from Dr. Lewis:
Question 6:
The authors report that bacterial vaginosis has been epidemiologically associated with obesity. Does that correlation persist after adjusting for race and socioeconomic status? It would be interesting to evaluate whether the higher glycemic load and lower nutritional density often found in areas of food deserts have a direct impact on the vaginal microbiome and dysbiosis Obesity has been associated with bacterial vaginosis in large epidemiological studies; one of the largest was one using data from the National Health and Nutrition Examination Survey, 2001 Survey, -2004 . 4 In this study, increasing body mass index (BMI) 6 In this study, the composition and functionality of the microbiota was found to reorganize substantially after delivery and was driven by body site, rather than delivery mode. There is clearly an enormous amount left to learn about determinants of a healthy infant microbiome.
